Back to Search Start Over

The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers

Authors :
Voahangy Randrianarison
Michel Perricaudet
Jean Feunteun
N Elie
Paule Opolon
Nicolas Foray
Didier Marot
S Brailly-Tabard
Elisabeth Connault
Matrice extracellulaire et régulations cellulaires (MERC)
Université de Reims Champagne-Ardenne (URCA)-Centre National de la Recherche Scientifique (CNRS)
Vectorologie et transfert de gènes (VTG / UMR8121)
Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS)
Génétique oncologique (GO - UMR 8125)
Rayonnement Synchrotron et Recherche Medicale (RSRM)
Université Joseph Fourier - Grenoble 1 (UJF)-European Synchrotron Radiation Facility (ESRF)-Institut National de la Santé et de la Recherche Médicale (INSERM)
European Synchrotron Radiation Facility (ESRF)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Gene Therapy, Gene Therapy, Nature Publishing Group, 2006, 13, pp.235-244, Gene Ther, Gene Ther, 2006, 13 (3), pp.235-44. ⟨10.1038/sj.gt.3302637⟩
Publication Year :
2005
Publisher :
Springer Science and Business Media LLC, 2005.

Abstract

International audience; The BRCA1 (breast cancer 1) breast cancer susceptibility gene is recognized as responsible for most familial breast and ovarian cancers and is suggested to be a tissue-specific tumor suppressor gene. In this report, we investigated the tissue specificity of tumor inhibitory activities induced by a recombinant adenovirus coding for wild-type BRCA1 (wtAdBRCA1). We demonstrated a pronounced in vitro antiproliferative effect on H1299 lung and HT29 colon cells upon infection with AdBRCA1. We describe a prolonged G1 cell cycle arrest associated with a decrease in the hyperphosphorylated form of Rb, suggesting that the Rb/E2F pathway is implicated in BRCA1-induced cell growth arrest. We also observed a significant antitumor effect in these pre-established subcutaneous tumors after in situ delivery of AdBRCA1, although these two tumors do not express wt p53, and also estrogen alpha and beta, progesterone and androgen receptors. Moreover, BRCA1 can induce a strong prolonged cell cycle arrest and apoptotic cell death but no significant antiangiogenic effect in H1299 tumors. Finally, our data indicate that intratumor administration of wtAdBRCA1 significantly inhibits growth of lung and colon steroid hormone-independent tumors.

Details

ISSN :
14765462 and 09697128
Volume :
13
Database :
OpenAIRE
Journal :
Gene Therapy
Accession number :
edsair.doi.dedup.....da7599b5e0fe1d823a6a8f7dda9bd012
Full Text :
https://doi.org/10.1038/sj.gt.3302637